• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊泡载体(脂质体、醇质体和 PEV)中双氯芬酸抑制小鼠皮肤炎症。

Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs.

机构信息

Dept. Scienze della Vita e dell'Ambiente, Sezione Scienze del Farmaco, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.

出版信息

Int J Pharm. 2013 Feb 25;443(1-2):128-36. doi: 10.1016/j.ijpharm.2012.12.041. Epub 2013 Jan 5.

DOI:10.1016/j.ijpharm.2012.12.041
PMID:23299087
Abstract

Diclofenac-loaded phospholipid vesicles, namely conventional liposomes, ethosomes and PEVs (penetration enhancer-containing vesicles) were developed and their efficacy in TPA (phorbol ester) induced skin inflammation was examined. Vesicles were made from a cheap and unpurified mixture of phospholipids and diclofenac sodium; Transcutol P and propylene glycol were added to obtain PEVs, and ethanol to produce ethosomes. The structure and lamellar organization of the vesicle bilayer were investigated by transmission electron microscopy and small and wide angle X-ray scattering, as well as the main physico-chemical features. The formulations, along with a diclofenac solution and commercial Voltaren Emulgel, were tested in a comparative trial for anti-inflammatory efficacy on TPA-treated mice dorsal skin. Vesicles were around 100 nm, negatively charged, able to encapsulate diclofenac in good yields, and disclosed different lamellarity, as a function of the formulation composition. Vesicular formulations promoted drug accumulation and reduced the permeation. Administration of vesicular diclofenac on TPA-inflamed skin resulted in marked attenuation of oedema and leucocyte infiltration, especially using PEVs. Histology confirmed the effectiveness of vesicles, since they provided an amelioration of the tissual damage induced by TPA. The proposed approach based on vesicular nanocarriers may hold promising therapeutic value for treating a variety of inflammatory skin disorders.

摘要

载有双氯芬酸的磷脂囊泡,即普通脂质体、醇质体和 PEV(含有渗透增强剂的囊泡)被开发出来,并研究了它们在 TPA(佛波酯)诱导的皮肤炎症中的疗效。囊泡由廉价且未纯化的磷脂和双氯芬酸钠混合物制成;添加 Transcutol P 和丙二醇以获得 PEV,并添加乙醇以产生醇质体。通过透射电子显微镜和小角 X 射线散射以及主要的物理化学特性研究了囊泡双层的结构和层状组织。制剂与双氯芬酸钠溶液和商业 Voltaren Emulgel 一起在 TPA 处理的小鼠背部皮肤的抗炎功效比较试验中进行了测试。囊泡约为 100nm,带负电荷,能够以良好的产率包封双氯芬酸钠,并根据制剂组成显示出不同的层状结构。囊泡制剂促进药物积累并减少渗透。将囊泡双氯芬酸钠施用于 TPA 炎症皮肤可显著减轻水肿和白细胞浸润,特别是使用 PEV 时。组织学证实了囊泡的有效性,因为它们改善了 TPA 诱导的组织损伤。基于囊泡纳米载体的这种方法可能对治疗各种炎症性皮肤疾病具有有前途的治疗价值。

相似文献

1
Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs.囊泡载体(脂质体、醇质体和 PEV)中双氯芬酸抑制小鼠皮肤炎症。
Int J Pharm. 2013 Feb 25;443(1-2):128-36. doi: 10.1016/j.ijpharm.2012.12.041. Epub 2013 Jan 5.
2
Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction.经皮递送双氯芬酸的透皮醇含药脂质体及其与皮肤相互作用的机制探讨。
Eur J Pharm Biopharm. 2011 May;78(1):27-35. doi: 10.1016/j.ejpb.2010.12.010. Epub 2010 Dec 15.
3
Topical anti-inflammatory potential of quercetin in lipid-based nanosystems: in vivo and in vitro evaluation.槲皮素在脂质基纳米系统中的局部抗炎潜力:体内和体外评估。
Pharm Res. 2014 Apr;31(4):959-68. doi: 10.1007/s11095-013-1215-0. Epub 2013 Dec 3.
4
Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.新型弹性膜囊泡(EMV)和醇质体介导的醋氯芬酸有效局部递送:一种治疗疼痛和炎症的新方法。
Drug Deliv. 2016 Oct;23(8):3135-3145. doi: 10.3109/10717544.2016.1155244. Epub 2016 Mar 10.
5
Close-packed vesicles for diclofenac skin delivery and fibroblast targeting.紧密堆积的囊泡用于双氯芬酸皮肤传递和成纤维细胞靶向。
Colloids Surf B Biointerfaces. 2013 Nov 1;111:609-17. doi: 10.1016/j.colsurfb.2013.07.014. Epub 2013 Jul 12.
6
Penetration enhancer-containing vesicles: composition dependence of structural features and skin penetration ability.含渗透增强剂的囊泡:结构特征和皮肤渗透能力的组成依赖性。
Eur J Pharm Biopharm. 2012 Oct;82(2):352-9. doi: 10.1016/j.ejpb.2012.06.015. Epub 2012 Aug 13.
7
Fabrication of quercetin and curcumin bionanovesicles for the prevention and rapid regeneration of full-thickness skin defects on mice.制备槲皮素和姜黄素生物纳米囊泡用于预防和促进小鼠全层皮肤缺损的快速再生
Acta Biomater. 2014 Mar;10(3):1292-300. doi: 10.1016/j.actbio.2013.11.005. Epub 2013 Nov 15.
8
Influence of the formulation on the in vitro transdermal penetration of sodium diclofenac. Evaluation of the topical and systemic anti-inflammatory activity in the rat.制剂对双氯芬酸钠体外透皮渗透的影响。大鼠局部和全身抗炎活性的评价。
Arzneimittelforschung. 1999 Dec;49(12):1012-7.
9
Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.含渗透促进剂的囊泡(PEV)作为米诺地尔经皮递送的载体。
Int J Pharm. 2009 Oct 1;380(1-2):72-9. doi: 10.1016/j.ijpharm.2009.06.040. Epub 2009 Jul 7.
10
Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.含有包裹双氯芬酸二乙胺的新型弹性囊泡的凝胶的抗炎活性。
Int J Pharm. 2008 Aug 6;360(1-2):156-63. doi: 10.1016/j.ijpharm.2008.04.033. Epub 2008 Apr 26.

引用本文的文献

1
Advances in nanotechnology for the therapy of bacterial pneumonia.用于治疗细菌性肺炎的纳米技术进展
Front Cell Infect Microbiol. 2025 Jul 28;15:1639783. doi: 10.3389/fcimb.2025.1639783. eCollection 2025.
2
Characterization Methods for Nanoparticle-Skin Interactions: An Overview.纳米颗粒与皮肤相互作用的表征方法:综述
Life (Basel). 2024 May 8;14(5):599. doi: 10.3390/life14050599.
3
Design, Formulation, and Characterization of Valsartan Nanoethosomes for Improving Their Bioavailability.缬沙坦纳米脂质体的设计、配方及特性研究以提高其生物利用度
Pharmaceutics. 2022 Oct 24;14(11):2268. doi: 10.3390/pharmaceutics14112268.
4
Ultraflexible Liposome Nanocargo as a Dermal and Transdermal Drug Delivery System.超柔性脂质体纳米载药系统作为一种皮肤和透皮给药系统。
Nanomaterials (Basel). 2021 Sep 29;11(10):2557. doi: 10.3390/nano11102557.
5
Antimicrobial Effect of and var. as Raw Extracts and Nanovesicles.[提取物名称]及[变种名称]作为粗提物和纳米囊泡的抗菌作用
Pharmaceutics. 2019 May 14;11(5):234. doi: 10.3390/pharmaceutics11050234.
6
Liposomes with an Ethanol Fraction as an Application for Drug Delivery.乙醇部分脂质体作为药物传递应用。
Int J Mol Sci. 2018 Nov 29;19(12):3806. doi: 10.3390/ijms19123806.
7
Solutol HS15 based binary mixed micelles with penetration enhancers for augmented corneal delivery of sertaconazole nitrate: optimization, in vitro, ex vivo and in vivo characterization.基于 Solutol HS15 的二元混合胶束与渗透促进剂用于增强硝酸舍他康唑的角膜递药:优化、体外、离体和体内评价。
Drug Deliv. 2018 Nov;25(1):1706-1717. doi: 10.1080/10717544.2018.1497107.
8
Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials.乙醇胺纳米载体:成分和制剂技术对乙醇胺纳米粒性质、体内研究及临床试验的影响
Int J Nanomedicine. 2016 May 25;11:2279-304. doi: 10.2147/IJN.S105016. eCollection 2016.
9
Statistical optimization of tretinoin-loaded penetration-enhancer vesicles (PEV) for topical delivery.用于局部给药的载维甲酸渗透促进囊泡(PEV)的统计优化。
Daru. 2016 Feb 29;24:7. doi: 10.1186/s40199-016-0142-0.
10
Topical anti-inflammatory potential of quercetin in lipid-based nanosystems: in vivo and in vitro evaluation.槲皮素在脂质基纳米系统中的局部抗炎潜力:体内和体外评估。
Pharm Res. 2014 Apr;31(4):959-68. doi: 10.1007/s11095-013-1215-0. Epub 2013 Dec 3.